Bipolar Treatments- AEDs Used Flashcards

1
Q

AEDs used in BPD

A

VPA, LTG, CBZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AEDs are most likely used in patients with what PMH?

A

Substance abuse history or active misuse- it can result in additive hepatotoxicity and increased suicide risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When to use VPA in BPD

A

Used alone or in combo with other drugs (Li, CBZ, APS) for acute treatment of manic or mixed episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

VPA BBW

A

Pancreatitis and/or liver toxicity, hepatotoxicity, urea disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should you have patients report (in relation to the VPA BBW)

A

Flu-like symptoms, GI pain, yellowing of skin, dark urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

VPA side effects that are dose-related

A

GI upset, tremor, sedation, alopecia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How to manage VPA dose-related complications

A

GI symptoms can go away on their own, but try taking it with food, give ER formulations, and/or move to HS dosing to reduce sedation. Alopecia is reversible if you switch to another med

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other VPA side effects (the ones that aren’t dose-related)

A

Prolonged bleeding, weight gain, hyperammonemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

VPA monitoring

A

CBC with diff
Baseline LFTs
Baseline renal function (Screen and BUN)
Serum drug concentrations 3-5 days after initiation or when stable dose established
Weight
Ammonia if hyperammonemia is suspected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When to use LTG in BPD

A

Alone or in combo with other drugs for long-term maintenance treatment of BP-I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

VPA vs. LTG for BP depression: which one’s better?

A

LTG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LTG dosing: what’s the caveat?

A

It needs slow titration and missing doses require re-titration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens to the dose of LTG when combining with VPA?

A

The dose gets cut in half!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LTG’s worst side effect

A

SJS!!!!!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Other LTG side effects (besides SJS)

A

Aseptic meningitis, prodrome chills, sore throat, fever, increased risk of heart arrhythmias in patients with heart disease, abnormal ECG, chest pain, loss of consciousness, cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LTG monitoring

A

CBC with diff
LFTs
Renal function (SCr and BUN)
Weight
Rash development (SJS)

17
Q

Only CBZ formulation used for BPD

A

Equetro (CBZ ER)

18
Q

When to use CBZ in BPD

A

Used alone or in combination with other drugs (Li, VPA, APS) for acute and long-term maintenance treatment of mania or mixed episodes for BP-I

(Not supported for maintenance use and it’s off-label???)

19
Q

What patients should you use CBZ in?

A

Reserve CBZ for patients who aren’t able to tolerate or have an inadequate response to PTG or VPA

20
Q

CBZ DDIs

A

Strong inducer of many CYP enzymes and can affect the metabolism of SSRIs, TCAs, MAOIs, and other mood stabilizers

21
Q

That one weird feature about CBZ

A

It auto induces its own metabolism

22
Q

CBZ side effects

A

Neutropenia, agranulocytosis, BONE MARROW SUPPRESSION, leukopenia, hematologic disease, SJS/TEN risk, hyponatremia, increased ADH release, porphyria

23
Q

Because of CBZ’s risk of leukopenia, what’s CI’ed?

A

MAOI therapy, nefazodone, lurasidone

24
Q

How can you find out if a patient is at risk of getting SJS/TEN from CBZ?

A

Genomic testing for HLA-B*15:02 – if the test is positive, don’t give them CBZ

25
Q

CBZ monitoring

A

CBC with diff
ECG
LFTs
TSH
renal function
serum electrolytes
weight
HLA-B*1502
rash development